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Guanine-rich nucleic acid sequences can adopt G-quadruplex structures stabilized by layers of four Hoogsteen-paired guanine
residues. Quadruplex-prone sequences are found in many regions of human genome and in the telomeres of all eukaryotic
organisms. Since small molecules that target G-quadruplexes have been found to be eﬀective telomerase inhibitors, the
identiﬁcation of new speciﬁc ligands for G-quadruplexes is emerging as a promising approach to develop new anticancer drugs.
Distamycin A is known to bind to AT-rich sequences of duplex DNA, but it has recently been shown to interact also with
G-quadruplexes. Here, isothermal titration calorimetry (ITC) and NMR techniques have been employed to characterize the
interaction between a dicationic derivative of distamycin A (compound 1) and the [d(TGGGGT)]4 quadruplex. Additionally,
to compare the binding behaviour of netropsin and compound 1 to the same target, a calometric study of the interaction between
netropsin and [d(TGGGGT)]4 has been performed. Experiments show that netropsin and compound 1 a r ea b l et ob i n dt o
[d(TGGGGT)]4 with good aﬃnity and comparable thermodynamic proﬁles. In both cases the interactions are entropically driven
processes with a small favourable enthalpic contribution. Interestingly, the structural modiﬁcations of compound 1 decrease the
aﬃnity of the ligand toward the duplex, enhancing the selectivity.
1.Introduction
It is well known that G-rich sequences can adopt unusual
DNA secondary structures with biological signiﬁcance, the
G-quadruplexes. These structures are four-stranded helical
complexes, composed of stacks of G-tetrads, a cyclic array
of four guanine bases which are connected by Hoogsteen
hydrogen bonding. The phosphodiester backbones of the
four quadruplex-forming strands could be in parallel or
antiparallel relative orientation, generating grooves of dif-
ferent width and several loops arrangement. Generally, the
formation of G-quadruplexes requires the presence of metal
cations that selectively bind to guanine O6 carbonyl groups
in the central cavity generated by the stacked layers of G-
tetrads [1].
Sequences with propensity to form G-quadruplexes have
been identiﬁed in biologically signiﬁcant genomic regions
such as telomeres or oncogene promoter regions [2, 3],
which have emerged as potential targets for anticancer
drug development. Very importantly, DNA G-quadruplex
structures that form in the promoter region of oncogenes
have recently showed to play a role in the control of gene
expression and the modulation of such expression could be
achieved by targeting these structures [4].
Telomeric sequences, which are found at the ends of
eukaryotic chromosomes, consist of G-rich repeats on the
single-stranded 3  end. Oligonucleotides corresponding to
the G-rich 3  strand of telomeric DNA of a variety of
organisms have been shown to fold into G-quadruplex
DNA structures [5]. The truncated sequence of Tetrahy-
mena telomeric DNA, d(TGGGGT), forms a tetramolecular
quadruplex in presence of cations, with a parallel-stranded,
right-handed helical structure containing four equivalent
grooves [6].2 Journal of Nucleic Acids
The biological importance of telomeric G-quadruplex
structures arises from the evidence that high telomerase
activity (not present in somatic cells) has been implicated
in about 85% of tumours [7]. The telomerase elongates the
G-rich strand of telomeric DNA, leading the cancer cells to
inﬁnite lifetime. For that reason, the inhibition of telomerase
has become an interesting strategy for the anticancer therapy
[8]. Since the formation of G-quadruplexes by telomeric
DNA inhibits the activity of telomerase, small molecules that
stabilize the G-quadruplex structures could potentially be
eﬀective chemotherapeutic agents [9].
In this scenario, the identiﬁcation of new ligands that
are speciﬁc for G-quadruplex structures is emerging as
a promising approach to develop new anticancer drugs.
Despite the fact that the structures of G-quadruplexes diﬀer
considerably from the double helix, the design of selective
quadruplex ligands is very diﬃcult, because the structure of
G-quadruplexes varies in several diﬀerent ways, including
number and orientation of strands, grooves width, and
loops topology [1]. Nevertheless, a number of G-quadruplex
binding agents has been proposed so far and some of these
have been demonstrated to be eﬀective telomerase inhibitors
[10].
Most of the reported G-quadruplex ligands interact with
the outer G-tetrads of the structures through π-π stacking
interactions [11]. The only groove binder experimentally
proven to date has been investigated in our laboratories; it
is the distamycin A that interacts in a groove-binding mode
with the quadruplex [d(TGGGGT)]4 [12]. This ﬁnding,
along with the observation that derivatives of distamycin
could be eﬀective inhibitors of the human telomerase [13],
has stimulated other investigations. In a previous study, we
investigated the importance of the crescent shape extension
by varying the pyrrole units number in distamycin A [14,
15]. We focused our attention on the interaction of two
carbamoyl analogues of distamycin A, containing four and
ﬁve pyrrole units, respectively. Experiments revealed that the
presence of one additional pyrrole unit aﬀects the aﬃnity as
well as the stoichiometry of the binding whereas the addition
of two pyrrole units leads to a total loss of interaction
between the derivative and the [d(TGGGGT)]4.
In this work, we evaluate the eﬀect of a second cationic
group, placed at the end of the molecule, on the inter-
action with DNA molecules. In particular, we report a
calorimetric and NMR study of the interaction between the
[d(TGGGGT)]4 quadruplex and a new distamycin A deriva-
tive (compound 1, Figure 1), where the initial formamide
group is replaced by a charged N-formimidoil moiety.
In addition, since compound 1 can also be considered
as an analogue of netropsin because it presents one pyrrole
unit more than netropsin (three instead of two), but two
cationic ends like it (even if diﬀerent groups), we compare
the binding of compound 1 to [d(TGGGGT)]4 with the
binding of netropsin to the same target.
Finally, to investigate the selectivity of compound 1 for
the G-quadruplex relative to duplex, we also performed a
study of the interaction between the drug and the self-
complementary DNA duplex d(CGCGAATTCGCG)2. This
symmetric dodecamer was chosen because (a) it contains
the central AATT core, which is considered the speciﬁc
binding site fordistamycin and netropsin; (b) the interaction
with netropsin is well characterized in literature, from both
structural and thermodynamic point of view [16–19].
2.MaterialsandMethods
2.1.Materials. Thed(TGGGGT)andd(CGCGAATTCGCG)
oligonucleotidesequencesusedforthisstudywerepurchased
from the Primm Company (Milan, Italy).
Quadruplex and duplex samples were prepared by dis-
solving the lyophilised compound in a buﬀer solution con-
taining 20mM phosphate with 70mM KCl, 0.1mM EDTA at
pH 7.0. The resulting solutions were annealed by heating at
95
◦C for 5 minutes. The solutions were then slowly cooled
to room temperature and equilibrated for 1 day at 4◦C. The
concentration of oligonucleotides was determined by UV
adsorption measurements at 90
◦C using molar extinction
coeﬃcient values ε(260nm) of 57800 and 110700M−1 cm−1 for
d(TGGGGT) and d(CGCGAATTCGCG), respectively. The
molar extinction coeﬃcients were calculated by the nearest
neighbour model [20].
Compound 1 has been synthesized as reported in
the literature [21], while netropsin has been purchased
from Sigma-Aldrich (St. Louis, MO). Drug solutions have
been prepared in the same buﬀer used for the oligonu-
cleotides, and the concentration has been estimated by
UV spectroscopy using the calculated extinction coeﬃ-
cient value ε(297nm) of 30000M−1 cm−1 for compound 1
and the reported extinction coeﬃcient value ε(296nm) of
21500M−1 cm−1 for netropsin [22].
2.2. Nuclear Magnetic Resonance Experiments. [d(TGG-
GGT)]4 and d(CGCGAATTCGCG)2 NMR samples were
prepared at a concentration of 2mM and 1mM respec-
tively, in 0.2ml (H2O/D2O9 : 1 )b u ﬀer solution having
10mM KH2PO4/K2HPO4, 70mM KCl, 0.1mM EDTA, and
pH 7.0.NMR spectra were recorded with Varian UnityINOVA
700MHz spectrometer. 1H chemical shifts were referenced
relative to external sodium 2,2-dimethyl-2-silapentane-5-
sulfonate (DSS). 1D proton spectra of samples were recorded
using pulsed-ﬁeld gradient DPFGSE for H2O suppression
[23, 24].
2.3. Isothermal Titration Calorimetry Experiments. ITC
experiments were carried out at 298K using a high-
sensitivity CSC-5300 Nano-ITC microcalorimeter from
Calorimetry Science Corporation (Lindon, Utah) with a cell
volume of 1ml. Before each ITC experiment, the pH of
each solution was checked, the reference cell was ﬁlled with
deionised water, and the DNA solutions were degassed for
5 minutes to eliminate air bubbles. Care was taken to start
the ﬁrst addition after baseline stability had been achieved.
Ineachtitration,volumesof5–10μLofasolutioncontaining
compound 1 or netropsin at a concentration of 600–700μM
were injected into a solution of quadruplex or duplex DNA
(30μM) in the same buﬀer, using a computer-controlled
250μL microsyringe. In order to allow the system to reachJournal of Nucleic Acids 3
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Figure 1: (a) Chemical structures of netropsin, (b) distamycin A, and (c) compound 1.
theequilibrium,weappliedaspacingof300or400sbetween
each ligand injection. Heat produced by ligands dilution was
evaluated by performing a control experiment, titrating each
ligand into the buﬀer alone. The interaction heat for each
injectionwascalculatedaftercorrectionfortheheatofligand
dilution. The corrected heat values were plotted as a function
of the molar ratio, to give the corresponding binding
isotherms. The resulting isotherms were ﬁtted to a single set
of identical sites model employing a nonlinear least-squares
minimisationalgorithmtoatheoreticaltitrationcurve,using
the program Bindwork from Calorimetry Science Inc. ΔH◦
(reactionenthalpychangeinkJmol−1),Kb (bindingconstant
in M−1), and n (number of binding sites) were the ﬁtting
parameters. The Gibbs energy and the entropic contribution
were calculated using the relationships ΔbG◦ =− RT ln Kb,
(R = 8.314Jmol
−1K
−1, T = 298K) and −TΔbS◦ = ΔbG◦ −
ΔbH◦.
3. Results
3.1. NMR Experiments. The addition of compound 1 to
the quadruplex [d(TGGGGT)]4 (Figure 2) caused gradual
changes in the chemical shift and a broadening of DNA
proton resonances in the 1H-NMR spectra. The titration was
virtually completed at ligand:DNA ratio of 2:1. The four
strands resulted to be magnetically equivalent throughout
the titration, since no splitting of resonances was observed
at any stage. Furthermore, a single set of signals was
present for derivative 1 protons throughout the whole NMR
titration, which only grew in intensity and did not show
any signiﬁcant change in chemical shift values by increasing
ligand concentration.
We also studied the interaction of compound 1 with the
DNA duplex d(CGCGAATTCGCG)2 containing the central
AATT core, which is considered the speciﬁc binding site
for distamycin and netropsin, to evaluate a possible selec-
tivity of this analogue. The 1H-NMR spectrum (700MHz,
T = 25
◦C) of d(CGCGAATTCGCG)2 turned out to be
consistent with the assignment already published by Hare
et al. (taking in due account the diﬀerent temperature at
which it has been assigned) [25]. The NMR titration of
d(CGCGAATTCGCG)2 with 1 is reported in Figure 3.I n
this case, most of the DNA resonances turned out to be not
aﬀected by the addition of ligand, but some resonances of
r e s i d u e sC 1 ,A 5 ,A 6 ,T 7 ,T 8 ,C 9 .
3.2. ITC Experiments. Examples of the raw ITC and inte-
grated heat data for the titration of [d(TGGGGT)]4 quadru-
plex with netropsin and compound 1 are shown in Figure 4.
The ITC data for drugs binding to [d(TGGGGT)]4 indicate,
in both cases, the formation of a 2:1 (drug:quadruplex)
complex with good aﬃnity. The raw data for the titration
of drugs with [d(TGGGGT)]4 (insets in Figure 4) indicate
an exothermic interaction, based on the positive values
observed for the peaks. With each injection of ligand, less
and less heat release was observed until constant values were
obtained, reﬂecting, in both cases, a saturable process. The
thermodynamic results obtained from ﬁtting the ITC data
for netropsin and compound 1 binding to [d(TGGGGT)]4
are given in Table 1. The values of the binding constants and
the Gibbs energy changes (−34kJmol−1 and −36kJmol−1
for netropsin and compound 1, resp.) indicate that, from
a thermodynamic point of view, the interactions with the
quadruplex molecule are favoured at 25
◦C.4 Journal of Nucleic Acids
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Figure 2: NMR titration of [d(TGGGGT)]4 with derivative 1 (700MHz, T = 25
◦C). 2mM (8mM single strand concentration), in 0.2ml
(H2O/D2O9:1 )b u ﬀer solution having 10mM KH2PO4, 70mM KCl, 0.2mM EDTA, and pH 7.0. Equivalents of the drug are reported on
the left of each spectrum.
Table 1: Thermodynamic parameters for the interaction of compound 1 and netropsin with [d(TGGGGT)]4 determined by ITC at 25
◦C
and pH 7.0.
Ligand nK b(× 106 M−1) ΔbH◦ (kJmol−1) TΔbS◦ (kJmol−1) ΔbG◦ (kJmol−1)
Compound 1 2.0 ± 0.1 1.9 ± 0.2 −11.0 ± 2.0 25 ± 2 −36 ± 2
Netropsin 2.0 ± 0.1 1.2 ± 0.1 −10.6 ± 1.0 23 ± 2 −34 ± 2
The values of ΔH◦ and TΔS◦ show that in both cases
the interactions are associated with a favourable binding
enthalpy (−10.6kJmol−1 and −11.0kJmol−1 for netropsin
and compound 1, resp.), however, the binding processes are
always entropically driven (23kJmol−1 and 25kJmol−1 for
netropsin and compound 1,r e s p . ) .
Finally, we also performed experiments on the intera-
ction of compound 1 with the DNA duplex d(CGC-
GAATTCGCG)2 containing the central AATT core, which
is considered the speciﬁc binding site for distamycin and
netropsin, to evaluate if the structural modiﬁcations of
compound 1 inﬂuence the binding. An example of the raw
ITC data for the titration of the d(CGCGAATTCGCG)2
duplex with compound 1 is shown in Figure 5.R e s o l v a b l e
binding isotherm was never obtained for the interaction of
compound 1 with duplex using any combination of reactant
concentrations, suggesting low aﬃnity of the molecule for
the investigated duplex.
4. Discussion
Distamycin and netropsin have been recognized for decades
as nonintercalative DNA binding ligands that show speci-
ﬁcity for the minor groove of dA·dT base pairs [22, 26]. The
binding of the drugs to duplex DNA involves an electrostatic
componentfromthecationicends,hydrogenbondsfromthe
amide NH groups, and van der Waals interactions with the
wall of the groove. Some years ago, NMR studies indicated
that, depending on DNA sequence, some binding sites can
accommodate two distamycin molecules side-by-side in an
antiparallelorientation[27].Inthis2:1complexeachligand
molecule preserves all the molecular recognition elements
of groove binders. In contrast to distamycin, the dication
netropsin binds only as a single molecule per binding
site, suggesting that the side-by-side arrangement of two
molecules is inhibited by charge repulsions. Both drugs have
been shown little or no aﬃnity for single-stranded DNA or
RNA or for double-stranded RNA or DNA-RNA hybrids as
well as they do not bind to the A helix or the left-handed Z-
DNA [26, 28].
Surprisingly, distamycin A has recently been shown to
interact also with four-stranded parallel DNA quadruplexes
[12, 29, 30]. Particularly, we have proved, by using NMR and
ITC methodology, that distamycin is able to interact with
the quadruplex [d(TGGGGT)]4. We showed that four ligand
molecules bind as antiparallel dimers to the quadruplex in
two opposite grooves, establishing hydrogen bonds with the
guanine bases and strong coulombic interactions between
the positively charged amidinium moiety of the ligand and
the backbone phosphate groups of the quadruplex [12]. On
the other hand, netropsin turned out to possess a lower
aﬃnity(NMRdata)towardsthequadruplex[d(TGGGGT)]4
[29], even if, till now, this has never been conﬁrmed by
ITC. Interestingly, it seems that netropsin is not able to bind
the quadruplex in dimeric form, most probably due to the
doubly charged nature of molecule that prevents a side-by-
side arrangement into the grooves.
In order to evaluate the binding properties of derivative
1, and to perform a direct comparison with the binding
behaviour of distamycin A and netropsin, [d(TGGGGT)]4
has been titrated with 1 at the same experimental condi-
tions (buﬀer, temperature, DNA concentration) used for
distamycin A [29]. As far as distamycin A is concerned,
below 2:1 ligand:quadruplex stoichiometry, the addition of
distamycin A to [d(TGGGGT)]4 caused gradual changing
in chemical shift of the signal of the quadruplex, whereasJournal of Nucleic Acids 5
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Figure 3: Expanded region of the 1H-NMR titration of
d(CGCGAATTCGCG)2 with derivative 1 (700MHz, T = 25
◦C).
1mM (4mM single strand concentration), in 0.2ml (H2O/D2O
9:1)buﬀer solution having 10mM KH2PO4,7 0m MK C l ,0 . 2m M
EDTA, and pH 7.0. Equivalents of the drug are reported on the left
of each spectrum. Residues that are slightly aﬀected by the binding
are indicated.
further addition of drug caused the appearance of a new
set of proton signals, whose intensities rose by increasing
the amount of drug with the concomitant falling oﬀ of the
original signals which completely disappeared at a ratio of
4:1 drug-DNA. Diﬀerently, the NMR titration proﬁle of 1
(Figure 2) turned out to be very diﬀerent from that observed
inthecaseofdistamycinAandclearlysuggeststhatderivative
1 binds the quadruplex in a fast process on the NMR time
scale,verysimilarlytotheNMRtitrationproﬁleobservedfor
netropsin [29].
In order to preliminarily evaluate the binding site of
derivative 1, a comparison of resonances of some protons
of the uncomplexed DNA and the complexed one has been
done. In particular, we report the Δδ values (chemical shifts
of the complex minus free DNA) of aromatic, methyl, and
imino protons in Figure 6. Interestingly, all analyzed DNA
resonances shifted. Nevertheless, the signal of the protons of
T1 residue shifted the least, whereas the ones of residue T6
the more. In any case, a general shift of the aromatic and
imino signals could be observed also for the G2, G3, G4, and
G5.Thismeansthat,basically,derivative1isabletorecognize
most of the molecule surface.
On the other hand, the addition of 1 to d(CGC-
GAATTCGCG)2 aﬀected only slightly some DNA reso-
nances. In particular, at 2:1 (drug/DNA) molar ratio the
aromatic protons of residue C1, A5, A6, T7, T8, C9 residues
underwent to a shift of only 0.03, 0.01, 0.01, 0.02, 0.03, and
0.01ppm,respectively,indicatingaverypooraﬃnitytowards
the dodecamer.
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Figure 4: Raw ITC data (insets) and binding isotherms for titration
of [d(TGGGGT)]4 with netropsin (a) and with compound 1 (b).
ITC is an useful methodology for a complete under-
standing of drug-DNA interactions, and it has been applied
many times to determine the thermodynamic properties
of drug-quadruplex interactions [31]. Indeed, ITC is the
only technique that directly measures the binding enthalpy
change for the formation of a complex, allowing the free
energy change to be dissected into the enthalpic and entropic
contribution to the association process. This reveals the
nature of the forces that drive the binding and can provide
insight into the nature of the intermolecular contacts formed
and even into changes in solvation [19]. The understanding
of those factors can be helpful in both screening among
various drugs and optimizing the drug-target interactions,
to direct the design of new drugs.
ITC experiments reveal that both compound 1 and
netropsin bind to the investigated quadruplex. The thermo-
dynamic proﬁles of the two drug-quadruplex interactions
are qualitatively similar and in both cases the stoichiom-
etry observed is 2:1 (drug:quadruplex). Interestingly, the
thermodynamic parameters determined by ITC (Table 1)6 Journal of Nucleic Acids
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Figure 5: Raw ITC data for titration of d(CGCGAATTCGCG)2
duplex with compound 1. With each injection of ligand, constant
heat release was observed due only to ligand dilution.
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Figure 6: Diﬀerence in chemical shifts (Δδ) of DNA upon binding
of 1(complex 1: DNA minus DNA alone) with [d(TGGGGT)]4. Δδ
valuesarereportedforimino(lightgray),aromatic(darkgray),and
methyl (black) protons.
indicate that the association reactions of both ligands with
[d(TGGGGT)]4 are entropically driven processes, even if the
direct ITC measurements of the binding enthalpy change
indicate that also the enthalpic contribution favours the
associations. In the case of the interaction of distamycin with
[d(TGGGGT)]4, similar results were obtained (entropically
driven process with a small favourable enthalpic contribu-
tion), except for stoichiometry and magnitude of binding
constant.
As reported in the literature many times, a groove bind-
ing is generally characterized by a large favourable increase
of entropy and a small favourable or unfavourable enthalpy
change [32]. This could be mainly due to the fact that the
association reaction is driven in large part by a hydrophobic
eﬀect and the favorable entropy is derived from the release of
bound water molecules from the DNA and drug upon com-
plexformationaswellasreleaseofcounterionsuponbinding
of cationic ligands. Interestingly, the entropically driven
interactions of the compound 1 and of netropsin suggest a
groove-binding mechanism also in these cases, as observed
for distamycin A. Additionally, in contrast to many other
groove binders, netropsin binding to duplex DNA is accom-
panied on average by a favourable enthalpy change. This is
the result of both electrostatic interactions and hydrogen
bonds formation between netropsin molecule and DNA. A
favourable enthalpy change is observed by ITC for netropsin
binding to [d(TGGGGT)]4 as well as for compound 1,
suggesting once again a similar groove binding mode.
As stated before, the stoichiometry obtained for the asso-
ciation of the investigated ligands to [d(TGGGGT)]4 is 2:1
(drug:quadruplex), while for distamycin a stoichiometry of
4:1 was found. This ﬁnding is consistent with the observa-
tionthatthedistamycinmoleculesareabletobindasdimers,
while netropsin (and probably also compound 1)i sn o ta b l e
to dimerise because of charge repulsions. Notably, in the
distamycin-[d(TGGGGT)]4 complex,eachdistamycindimer
expands its bounded groove (similarly to that observed with
duplex DNA), with concomitant reduction of the size of the
adjacent ones, preventing a further interaction with other
ligand molecules. In the binding of netropsin to duplex
DNA the minor groove is widened by 0.5–2.0 ˚ A by the
entry of the drug [16]. We can speculate that the binding
of the two netropsin molecules to [d(TGGGGT)]4 could
similarly expand the bounded grooves, reducing the size of
the adjacent ones and preventing more interactions.
The experiments on the interaction of compound 1
with the DNA duplex d(CGCGAATTCGCG)2 show that
compound 1 has a poor aﬃnity for the investigated duplex,
while it is well known that both distamycin and netropsin
have a high binding constant (between 106 and 108 M−1)f o r
that target containing the speciﬁc binding site. This ﬁnding
demonstrates that the structural modiﬁcations of compound
1 decrease the aﬃnity of the ligand toward the duplex,
enhancing the selectivity.
5. Conclusions
The combination of calorimetric and NMR methodologies
hasenabledustodemonstratethatnetropsin andcompound
1 are able to bind to [d(TGGGGT)]4 with good aﬃnity,
forming, in both cases, a 2:1 (drug:quadruplex) complex.
Very interestingly, this study shows that the structural
modiﬁcations of compound 1 do not inﬂuence, compared
to netropsin, the interaction with the quadruplex, but such
modiﬁcations decrease the aﬃnity of the ligand toward the
duplex, enhancing the selectivity.
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